MedPath

Interpersonal Psychotherapy for Depressed Adolescents Engaging in Non-suicidal Self-injury

Phase 1
Completed
Conditions
Depression
Self-injurious Behavior
Interventions
Behavioral: Interpersonal Psychotherapy for Depressed Adolescents
Registration Number
NCT00401102
Lead Sponsor
New York State Psychiatric Institute
Brief Summary

The purpose of this study is to examine the feasibility of using Interpersonal Psychotherapy for Depressed Adolescents (IPT-A) to treat adolescents who are experiencing symptoms of depression and are engaging in non-suicidal self-injurious behaviors. The trial will include recruiting 10 particpants, administering 12-sessions of individual IPT-A, and determining how the IPT-A protocol needs to be amended to adequately address the self-injury in addition to depression.

Detailed Description

Engagement in non-suicidal self-injury (NSSI), purposefully harming oneself without the conscious intent to die such as cutting or burning, is pervasive among adolescents. Lifetime prevalence estimates among community samples of high school students range from 13.0% to 23.2%. Despite the significance of this public health problem, there are no known interventions that successfully reduce the frequency of NSSI or prevent NSSI in adolescents. The goal of the current study is to develop an effective psychosocial intervention for NSSI among adolescents who are engaging in self-injury and have a depressive disorder. Specifically, we will amend Interpersonal Psychotherapy for Depressed Adolescents (IPT-A), a psychotherapy that has demonstrated efficacy in treating depressed adolescents (Mufson et al., 1994, 1999, 2004), for use with adolescents with depression who are engaging in NSSI, with the ultimate goal of curing the depression and NSSI. Ten participants will be administered IPT-A and assessed several times throughout the course of the trial. It is expected that IPT-A will be a useful treatment for co-morbid depression and self-injury, although adaptations to the protocol will likely be needed to address the behavioral aspect of the self-injury. Data analyses will be descriptive in nature and involve examining the individual trajectories of depression and NSSI over time. The data obtained from the current study will lay the groundwork for an ultimate randomized controlled trial in which we plan to compare IPT-A versus nondirective supportive therapy in the treatment of co-morbid depression and NSSI.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  1. 12 to 18 years of age
  2. Diagnosis of MDD, Dysthymic Disorder, Depressive Disorder NOS, Adjustment Disorder with depressed Mood
  3. Non-suicidal self-injurious behavior
  4. CDRS >= 36
  5. C-GAS <= 65
  6. English speaking patient
  7. One English speaking caregiver -
Exclusion Criteria
  1. Suicide attempt within past 6 months or actively suicidal
  2. Severe incident of non-suicidal self-injury in past 3 months
  3. Severe episode of MDD
  4. Treatment resistant non-suicidal self-injury
  5. Frequent non-suicidal self-injury
  6. Mentally retarded
  7. Current diagnosis of: PTSD, OCD, Schizophrenia, Bipolar Disorder, Psychosis, Substance Dependence, ADHD
  8. Current substance use
  9. Currently in active treatment for same condition
  10. Currently taking antidepressant medication
  11. Medical illness likely to interfere with treatment -

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Interpersonal psychotherapyInterpersonal Psychotherapy for Depressed AdolescentsAll participants received interpersonal psychotherapy adapted for self-injury
Primary Outcome Measures
NameTimeMethod
CGI1 week
C-GAS1 month
CDRS1 week
Self-Injurious Thoughts and Behaviors Interview8 weeks
Self-injury Monitoring Card1 month
Secondary Outcome Measures
NameTimeMethod
Beck Depression Inventory2 weeks
Multidimensional Anxiety Scale for Childrenrecently

Trial Locations

Locations (1)

New York State Psychiatric Institute

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath